Flowr Co.’s brings THC medical cannabis harvest to Portugal

Sintra facility

TORONTO — The Flowr Corporation’s CEO Darryl Brooker says the global cannabis producer is poised for success in the European market with its Sintra facility in Portugal.

“We still firmly believe that Holigen’s team and assets are a unique entry point into the European Union. The Sintra facility is one of very few E.U. GMP certified facilities on the continent,” said Brooker in a statement.

“There are several reasons to be in Portugal – the regulatory landscape is changing, the cost structure is highly competitive and there are no real competitors in the premium cannabis market yet.”

The Sintra covers 25,000 square feet and has six grow rooms where the company produces THC strains including BC Black Cherry and BC Strawnana. Holigen expects to receive genetics for the strains from fellow cannabis company, Cookies, in the first quarter of 2022.

The company says it will harvest approximately 300 kilograms of medical cannabis in the first quarter of 2022 and over 2,000 kilograms of premium cannabis per year from the Sintra facility.

Holigen is also pursuing business-to-business medical cannabis bulk sales as a way to get product into multiple markets, and to generate immediate revenue.

The Flowr company has exported its flagship THC strains – BC Pink Kush, BC Black Cherry and BC Strawnana – from Canada to Portugal.

According to the company, preliminary testing results for BC Black Cherry indicate more than 25 per cent THC content and for BC Strawnana early testing at more than 27 per cent.